| Financial Year |
March 31 2023 |
| Monetary Funds |
7,720,489,758.18 |
| Held-for-trading Financial Assets |
977,224,794.45 |
| Notes Receivable |
1,092,026,414.14 |
| Accounts Receivable |
5,005,122,817.04 |
| Advances to Suppliers |
4,050,831,705.68 |
| Other Receivables |
154,200,368.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,269,177.55 |
| Inventories |
13,393,323,502.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,199,967,782.00 |
| Other Current Assets |
5,545,043,005.68 |
| Total Current Assets |
67,107,577,213.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
759,932,853.04 |
| Investment Properties |
60,220,184.65 |
| Fixed Assetes |
48,896,903,200.71 |
| Under-construction Projects |
7,342,310,942.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,531,403,337.01 |
| R&D expenses |
7,311,984.41 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,804,893.59 |
| Deferred Income Tax Assets |
129,077,191.28 |
| Other Non-Current Assets |
58,313,225.22 |
| Sub-Total of Non-Current Assets |
61,915,813,116.34 |
| Total Assets |
129,023,390,329.67 |
| Short-Term Loans |
5,149,475,337.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,926,988,149.80 |
| Accounts Payable |
10,122,086,447.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,248,330,785.93 |
| Taxes Payable |
290,187,716.71 |
| Interest Payable |
-- |
| Dividend Payable |
25,173,078.08 |
| Other payables |
4,806,291,624.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
928,553,371.83 |
| Other Current Liabilities |
788,580,714.81 |
| Sub-Total of Current Liabilities |
53,217,798,879.11 |
| Long-term Loans |
14,282,363,178.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,199,530.86 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
116,135,212.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,568,729,304.47 |
| Total Liabilities |
68,786,528,183.58 |
| Paid-In Capital(Or Share Stock) |
6,908,632,499.00 |
| Capital Surplus |
13,906,931,361.25 |
| Surplus Reserve |
1,452,038,109.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
28,254,381,573.61 |
| Minority Stockholder's Interest |
9,662,505,736.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,574,356,409.98 |
| Owner's Equity（Stockholder's Equity） |
60,236,862,146.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
129,023,390,329.67 |
